Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 15;12(12):4055.
doi: 10.3390/jcm12124055.

Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study

Antonio Russo  1 , Mariantonietta Pisaturo  1 , Verdiana Zollo  1 , Salvatore Martini  1 , Paolo Maggi  2 , Fabio Giuliano Numis  3 , Ivan Gentile  4 , Nadia Sangiovanni  5 , Anna Maria Rossomando  6 , Vincenzo Bianco  7 , Giosuele Calabria  8 , Raffaella Pisapia  9 , Alessio Vinicio Codella  10 , Alfonso Masullo  11 , Elio Manzillo  12 , Grazia Russo  13 , Roberto Parrella  14 , Giuseppina Dell'Aquila  15 , Michele Gambardella  16 , Antonio Ponticiello  17 , Lorenzo Onorato  1 , Nicola Coppola  1 ; CoviCam Group
Affiliations

Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study

Antonio Russo et al. J Clin Med. .

Abstract

Background and aim: The nature of the association between obesity and poor prognosis of COVID-19 without the evaluation of other co-pathologies associated has not yet been clearly evaluated. The aim of the present pair-matched case-control study was to investigate the outcome of patients with SARS-CoV-2 infection in obese and non-obese patients matched considering gender, age, number of comorbidities, and Charlson Comorbidity Index.

Methods: All the adults hospitalized for SARS-CoV-2 infection and with BMI ≥ 30 kg/m2 were included (Cases). For each Case, two patients with BMI < 30 kg/m2 pair matched for gender, age (±5 years), number of comorbidities (excluding obesity), and Charlson Comorbidity Index (±1) were enrolled (Controls).

Results: Of the 1282 patients with SARS-CoV-2 infection followed during the study period, 141 patients with obesity and 282 patients without were enrolled in the case and control groups, respectively. Considering matching variables, there was no statistical difference between the two groups. Patients in the Control group developed more frequently a mild-moderate disease (67% vs. 46.1%, respectively), whereas obese patients were more prone to need intensive care treatment (41.8% vs. 26.6%, respectively; p = 0.001). Moreover, the prevalence of death during hospitalization was higher in the Case group than in the Control group (12.1% vs. 6.4%, p = 0.046).

Discussion: We confirmed an association between obesity and severe outcome of patients with COVID-19, also considering other factors associated with a severe outcome of COVID-19. Thus, in the case of SARS-CoV-2 infection, the subjects with BMI ≥ 30 kg/m2 should be evaluated for early antiviral treatment to avoid the development of a severe course.

Keywords: COVID-19; SARS-CoV-2 infection; mortality; obesity; severity of disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the patients included in the study.
Figure 2
Figure 2
(A) Survival curve estimate of patients stratified by BMI during hospitalization; (B) Survival curve estimate of ICU care of patients stratified by BMI during hospitalization.
See this image and copyright information in PMC

References

    1. WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. [(accessed on 20 September 2022)]. Available online: https://covid19.who.int/
    1. Macera M., De Angelis G., Sagnelli C., Coppola N. Vanvitelli COVID-19 group Clinical Presentation of COVID-19: Case Series and Review of the literature. Int. J. Environ. Res. Public Health. 2020;17:5062. doi: 10.3390/ijerph17145062. - DOI - PMC - PubMed
    1. Monari C., Sagnelli C., Maggi P., Sangiovanni V., Numis F.G., Gentile I., Masullo A., Rescigno C., Calabria G., Megna A.S., et al. More Severe COVID-19 in Patients with Active Cancer: Results of a Multicenter Cohort Study. Front. Oncol. 2021;11:662746. doi: 10.3389/fonc.2021.662746. - DOI - PMC - PubMed
    1. Pisaturo M., Calò F., Russo A., Camaioni C., Giaccone A., Pinchera B., Gentile I., Simeone F., Iodice A., Maggi P., et al. Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study. Front. Aging Neurosci. 2021;13:698184. doi: 10.3389/fnagi.2021.698184. - DOI - PMC - PubMed
    1. Russo A., Pisaturo M., Palladino R., Maggi P., Numis F.G., Gentile I., Sangiovanni V., Esposito V., Punzi R., Calabria G., et al. Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19—An Observational Retrospective Study. Pathogens. 2022;11:652. doi: 10.3390/pathogens11060652. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources